COMMUNIQUÉS West-GlobeNewswire

Mount Tam Biotechnologies Announces Stockholder Approvals
31/05/2018
NOVATO, CA, May 31, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to [...]
Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference
31/05/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, [...]
Menlo Therapeutics to Present at Upcoming Investor Conferences
31/05/2018
REDWOOD CITY, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
Intuitive Surgical Announces Innovative Single Port Platform — the da Vinci SP® Surgical System
31/05/2018
Allows for narrow access surgery using a single port SUNNYVALE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), today announced a new U.S. Food and Drug Administration (FDA) clearance [...]
Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology
31/05/2018
Clinical Benefit of Tonmya, an FDA-Designated Breakthrough Therapy for PTSD, was Evidenced in AtEase NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), presented data [...]
Oncolytics Biotech® Announces Public Offering of Common Shares
31/05/2018
CALGARY, Alberta and SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (OTCQX:ONCYD), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus turning [...]
Reata Announces Orphan Drug Designation From the European Commission for Bardoxolone Methyl for the Treatment of Alport Syndrome
31/05/2018
IRVING, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission (EC) has granted orphan drug [...]
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
31/05/2018
CHARLESTON, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna [...]
TRACON Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
31/05/2018
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and [...]
TRACON Pharmaceuticals Reports Granting of Inducement Award
31/05/2018
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a biopharmaceutical company that develops targeted therapies for cancer and wet age-related macular degeneration, announced today that it [...]
Myriad Genetics to Present at Two Upcoming Investor Conferences
31/05/2018
SALT LAKE CITY, May 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced that it will be presenting at two upcoming investor [...]
Fibrocell Announces Closing of $6.0 Million Registered Direct Offering
31/05/2018
EXTON, Pa., May 31, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Neos Therapeutics to Participate in Two June Conferences
31/05/2018
DALLAS and FORT WORTH, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019
31/05/2018
- Lead Investigational New Drug (“IND”) program for Alpha-1-antitrypsin deficiency (“A1AT”) received FDA’s orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019 - Second IND-track [...]
Molecular Templates to Present at the Jefferies Global Healthcare Conference
31/05/2018
AUSTIN, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered [...]
Metacrine to Present Role of FXR in Treating Inflammatory Bowel Disease at Digestive Disease Week 2018
31/05/2018
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company developing therapies to benefit patients with liver, gastrointestinal and metabolic diseases, today presented data showing [...]
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
31/05/2018
DUBIN, Ireland, May 31, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), “Avadel” or the “Company,” today announced that management will present at two upcoming investor conferences: The Jefferies 2018 [...]
Mersana Therapeutics to Present at the Jefferies Global Healthcare Conference
31/05/2018
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
POCML 4 Inc. Provides Further Details of Qualifying Transaction With MediPharm Labs Inc.
31/05/2018
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, May 31, 2018 (GLOBE [...]

Pages